Aarey Drugs & Pharmaceuticals Limited — Others, 27-06-2025: Disclosure under SEBI Takeover Regulations

The company has announced a board meeting to consider and approve the financial results for the quarter and half-year. This event is a key update for shareholders as these results will provide insight into recent operational performance and financial health, helping investors gauge the company’s momentum and future prospects. No other changes or developments were disclosed that might impact the business or share value.